The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

The RSV vaccine isn't needed annually like the flu vaccine ... In adults, the most frequently reported side effects have been ...

The retrospective cohort study evaluated the effects of the RSV vaccine in patients diagnosed with IBD aged older than 60 years using data from the TriNetX database. The participants were grouped ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo ... One way that we mitigated the effects of this kind of limited testing was by salvaging swabs that were used for ...

The FDA approved RSV vaccine Abrysvo, which protects against lung infections, for high-risk adults as young as 18 with diseases like COPD.

the company reported that a single 120µg dose of the vaccine led to “strong neutralising” responses against RSV-A and RSV-B. The commonly reported treatment-associated side effects were pain ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...

This summer, the FDA approved Moderna's mRESVIA RSV vaccine for adults ... In adults, the most frequently reported side effects have been soreness at the injection site, muscle pain, fatigue ...

The RSV vaccine leads to better health outcomes among older adults with IBD, including a lower risk for RSV pneumonia.

Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.